Basel Medical BMGL Income Statement (2024-2025)

NASDAQ BMGL
$4.43 +0.25 (+5.98%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Basel Medical Quarterly Income Statement

Periods 4 quarters
Latest Dec 2025

Basel Medical income statement data for the quarter ended Dec 2025. This income statement covers 4 quarters of results from Jun 2024 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Jun2024 Dec2024 Jun2025 Dec2025
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot) -0.35M-2.06M
Operating ExpensesOpex -0.47M-2.06M
Non-operating items
Non Operating Interest Expenses -0.10M-0.22M
Non Operating Investment IncomeNon-Op. Investment Inc. -0.33M
Net income details
Tax ProvisionsTaxes -388.00-0.18M
Additional items
Shares Outstanding 1.35M1.35M1.57M1.57M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 1.35M1.35M1.57M1.57M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 1.35M1.57M
Interest ExpensesInt Expense -0.10M-0.22M

Basel Medical Income Statement API

Pull Basel Medical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BMGL&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY